drugset / Trial / NCT00210444
Efficacy Study of Dysport® in the Treatment of Anal Fissure.
RandomizedParallel-groupOpen-labelTreatment
Summary
To evaluate the effect on healing rates of two different prognostic factors in patients treated with Dysport® for anal fissure: duration of fissure and dose of study drug
Timeline
- Start
- 2003-06
- Primary completion
- —
- Completion
- 2006-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |
Indications
No indication recorded.